Showing results (191-200 of 229) with videos related to
Sort By:
Pageof 23
Journal of Nanobiotechnology|April 30, 2026
Biomimetic PD-1 macrophage nanoplatform for Cip2a silencing and immune activation in oral squamous cell carcinomaChenyu Zhang, Zhe Yuan, Jie Zhou, et al.Plos One|February 18, 2021
Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosisKunkun Wang, Zhenfan Wang, Qiaozhu Zeng, et al.Molecular Pharmaceutics|March 27, 2014
Sequential release of autophagy inhibitor and chemotherapeutic drug with polymeric delivery system for oral squamous cell carcinoma therapyWuliji Saiyin, Dali Wang, Lili Li, et al.Angewandte Chemie (International Ed. in English)|November 10, 2023
Tailored Zwitterionic Hemicyanine Reporters for Early Diagnosis and Prognostic Assessment of Acute Renal FailureYa Zhou, Lijuan Zhu, Biaoxiang Liu, et al.Journal of Molecular Cell Biology|June 18, 2021
The septin complex links the catenin complex to the actin cytoskeleton for establishing epithelial cell polarityXueying Wang, Wenwen Wang, Xiwei Wang, et al.Environmental Toxicology|November 27, 2024
The Ameliorative Effect of Betulinic Acid on Oxidative Stress in Mice of Cyclophosphamide-Induced Liver DamageYou Huang, Chaoyang Ma, Lijuan Zhu, et al.Food Chemistry: X|December 25, 2023
Differential analysis of phytochemistry and antioxidant activity in five citrus by-products based on chromatography, mass spectrometry, and spectrum-effect relationshipsJiangyi Luo, Ling Liang, Qinling Xie, et al.Pharmacological Reports : PR|August 27, 2019
Protective effects of betulinic acid on intestinal mucosal injury induced by cyclophosphamide in miceXihong Wang, Zhihang Yuan, Lijuan Zhu, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 21, 2018
Betulinic acid attenuates dexamethasone-induced oxidative damage through the JNK-P38 MAPK signaling pathway in miceLijuan Zhu, Xianglian Yi, Jing Zhao, et al.Frontiers in Genetics|March 20, 2025
Multi-omics analysis reveals Jianpi formula-derived bioactive peptide-YG-22 potentially inhibited colorectal cancer via regulating epigenetic reprogram and signal pathway regulationJun Wang, Lijuan Zhu, Yuanyuan Li, et al.Pageof 23